Disc Medicine Valuation
| IRON Stock | 53.74 0.91 1.72% |
At this time, the firm appears to be undervalued. Disc Medicine shows a prevailing Real Value of USD66.93 per share. The current price of the firm is USD53.74. Our model computes the value of Disc Medicine from reviewing the firm fundamentals such as Current Valuation of 1.31 B, price to book of 4.00 X, and Shares Owned By Insiders of 11.32 % as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Disc Medicine's valuation include:
Undervalued
Today
Please note that Disc Medicine's price fluctuation is very steady at this time. Calculation of the real value of Disc Medicine is based on 3 months time horizon. Increasing Disc Medicine's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Disc Medicine is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Disc Stock. However, Disc Medicine's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 53.74 | Real 66.93 | Target 93.55 | Hype 54.16 | Naive 51.19 |
The intrinsic value of Disc Medicine's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Disc Medicine's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Disc Medicine helps investors to forecast how Disc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Disc Medicine more accurately as focusing exclusively on Disc Medicine's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Disc Medicine's intrinsic value based on its ongoing forecasts of Disc Medicine's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Disc Medicine's closest peers.
Disc Medicine Cash |
|
Disc Valuation Trend
Knowing Disc Medicine's actual value is paramount for traders when making sound investment determinations. Using both Disc Medicine's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Disc Medicine Total Value Analysis
Disc Medicine is currently estimated to have valuation of 1.31 B with market capitalization of 1.83 B, debt of 30 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Disc Medicine fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.31 B | 1.83 B | 30 M |
Disc Medicine Asset Utilization
One of the ways to look at asset utilization of Disc is to check how much profit was generated for every dollar of assets it reports. Disc Medicine shows a negative utilization of assets of -0.19 percent, losing USD0.001875 for each dollar of assets held by the firm. Inadequate asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Disc Medicine shows how discouraging it operates for each dollar spent on its assets.Disc Medicine Ownership Allocation
Disc Medicine holds a total of 34.57 Million outstanding shares. The majority of Disc Medicine outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Disc Medicine to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Disc Medicine. Please pay attention to any change in the institutional holdings of Disc Medicine as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Disc Medicine Profitability Analysis
Net Loss for the year was (109.36 M) with profit before overhead, payroll, taxes, and interest of 0.About Disc Medicine Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Disc Medicine. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Disc Medicine based exclusively on its fundamental and basic technical indicators. By analyzing Disc Medicine's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Disc Medicine's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Disc Medicine. We calculate exposure to Disc Medicine's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Disc Medicine's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -115 K | -120.8 K |
Disc Medicine Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 29.9 M |
Disc Medicine Current Valuation Indicators
Disc Medicine's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Disc Medicine's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Disc Medicine, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Disc Medicine's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Disc Medicine's worth.When determining whether Disc Medicine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Disc Medicine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Disc Medicine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Disc Medicine Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Disc Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Disc Medicine. If investors know Disc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Disc Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Disc Medicine is measured differently than its book value, which is the value of Disc that is recorded on the company's balance sheet. Investors also form their own opinion of Disc Medicine's value that differs from its market value or its book value, called intrinsic value, which is Disc Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Disc Medicine's market value can be influenced by many factors that don't directly affect Disc Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Disc Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Disc Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Disc Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.